Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Robert E Dudley"'
Autor:
Ronald S. Swerdloff, Robert E. Dudley
Publikováno v:
Therapeutic Advances in Urology, Vol 12 (2020)
Background: A novel formulation of oral testosterone undecanoate (TU) was studied in a long- and short-term phase III trial to evaluate safety and efficacy. Methods: Hypogonadal men (age 18–65 years; two morning serum testosterone (T)
Externí odkaz:
https://doaj.org/article/9a2bae31cb134e96babe3cb3ad18616b
Autor:
Stanton Honig, Marc Gittelman, Jed Kaminetsky, Christina Wang, John K. Amory, Nestor Rohowsky, Robert E. Dudley, B. Woun Seo, Jay Newmark, Ronald Swerdloff
Publikováno v:
The journal of sexual medicine. 19(12)
Background Long-term data evaluating the efficacy and safety of oral testosterone undecanoate (oral TU; JATENZO) in adult hypogonadal men provides important information for healthcare professionals who prescribe testosterone replacement therapy (TRT)
Autor:
Theodore Danoff, Ronald S. Swerdloff, Jed Kaminetsky, James Longstreth, Marc Gittelman, Robert E Dudley, Christina Wang, William B. White
Publikováno v:
The Journal of Clinical Endocrinology and Metabolism
Context A novel formulation of oral testosterone (T) undecanoate (TU) was evaluated in a phase 3 clinical trial. Objective Determine efficacy, short-term safety, and alignment of new oral TU formulation with current US approval standards for T replac
Autor:
Nestor Rohowsky, Ronald S. Swerdloff, Christina Yan Wang, Marc Gittelman, Parviz K. Kavoussi, B. Woun Seo, Robert E Dudley
Publikováno v:
Journal of Urology. 206
INTRODUCTION AND OBJECTIVE:An oral testosterone (T) replacement therapy (TRT) would be the preferred administration route for many hypogonadal men. Until recently, the only oral TRT approved in the...
Autor:
B. Woun Seo, Robert E Dudley, John K. Amory, Ronald S. Swerdloff, Nestor Rohowsky, Marc Gittelman
Publikováno v:
Journal of the Endocrine Society
Introduction: An oral testosterone (T) replacement therapy (TRT) would be the preferred choice for many hypogonadal men. Until recently, the only oral TRT approved in the US was methyl-T which has been associated with hepatotoxicity. The safety of a
Autor:
Robert E Dudley, Ronald S. Swerdloff
Publikováno v:
Therapeutic Advances in Urology
Therapeutic Advances in Urology, Vol 12 (2020)
Therapeutic Advances in Urology, Vol 12 (2020)
Background: A novel formulation of oral testosterone undecanoate (TU) was studied in a long- and short-term phase III trial to evaluate safety and efficacy. Methods: Hypogonadal men (age 18–65 years; two morning serum testosterone (T) Results: Oral
Autor:
Ronald S. Swerdloff, Robert E Dudley, Adrian S. Dobs, Theodore Danoff, John K. Amory, Christina Wang
Publikováno v:
Journal of the Endocrine Society
Introduction and Objective: A new, first-in-class oral testosterone (T) replacement therapy product [T-undecanoate (TU) capsules] was recently approved by FDA to treat hypogonadal men. Clinical trials were conducted to evaluate, in part, the impact o
Autor:
Theodore Danoff, Ronald S. Swerdloff, F. Bai, Jonas Čeponis, Andrew Leung, James Longstreth, Robert E Dudley, Laura Hull, Christina Wang
Publikováno v:
Andrology
Background Ex vivo androgen prodrug conversion by blood esterases after oral androgen ester administration may result in an overestimation of the measured blood androgens. Objective We investigated whether blood collection tubes with esterase inhibit
Publikováno v:
The Journal of Sexual Medicine. 18:S18-S19
Publikováno v:
The Journal of Sexual Medicine. 18:S15-S16